Advertisement
News
Subscribe to MDT Magazine News

Patients with severe non-inflammatory respiratory disease face anemia risk

March 31, 2011 10:33 am | by EurekAlert | Comments

(Wiley-Blackwell) The links between chronic obstructive pulmonary disease and anemia are already well known, but now a study of nearly 600 patients has found that anemia is also frequently found in patients with severe non-inflammatory respiratory diseases.

TOPICS:

AAIPharma Services Announces Promotion of Dean Shirazi

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

WILMINGTON, N.C., March 31, 2011 /- AAIPharma Services Corp., a leading provider of pharmaceutical product development and manufacturing services, announced today the promotion of Dean Shirazi, Ph.D., to Vice President, Analytical Development. Shirazi will assume the position effective...

TOPICS:

Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

ATLANTA, March 31, 2011 /- Digital Assent has expanded its leadership team to meet the rapidly growing demand for its award-winning PatientPad® solution.  The PatientPad is a self-service patient check-in and education solution designed to automate the patient intake process and...

TOPICS:
Advertisement

Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium

March 31, 2011 9:35 am | by Bio-Medicine.Org | Comments

RAMSEY, N.J., March 31, 2011 /- Top medical device manufacturers are supporting MPO Symposium Costa Rica, the leading medical device manufacturing conference series. Hologic, Hospira, Boston Scientific, Allergan, Siemens, as well as the Costa Rican government are active participants in...

TOPICS:

Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis

March 31, 2011 9:34 am | by Bio-Medicine.Org | Comments

NEW YORK, March 31, 2011 /- Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind  Phase II clinical trial of obeticholic acid (OCA) given as monotherapy to patients with primary biliary cirrhosis (PBC).  The study...

TOPICS:

OncoSec Medical Closes $1.1M Financing

March 31, 2011 9:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, March 31, 2011 /- OncoSec Medical Inc. (OTC BB: ONCS), a developer of innovative medical approaches to treat solid tumor cancers, announced today that it has raised more than $1 million of new capital through the issuance of units to three institutional investors. OncoSec...

TOPICS:

Del. judge rules in pacemaker patent dispute

March 31, 2011 8:45 am | by The Associated Press | Comments

A federal judge in Delaware has ruled that certain heart pacemakers sold by Medtronic Inc. do not infringe patents claimed by rival medical device manufacturer Boston Scientific Corp.Ruling in a long-running dispute between the two companies, the judge granted a request by Minneapolis-based...

Fluvastatin enhances HCV response in combination with interferon and ribavirin

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) New data presented today at the International Liver CongressTM confirm the antiviral activity of fluvastatin -- commonly used as a cholesterol-lowering treatment -- in patients with chronic hepatitis C (HCV).

TOPICS:
Advertisement

First study in decade provides hope for patients suffering from primary biliary cirrhosis

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated...

TOPICS:

Lymphocyte-hepatocyte interactions: hepatitis C virus changes the rules

March 31, 2011 8:39 am | by EurekAlert | Comments

(European Association for the Study of the Liver) New data presented at the International Liver Congress today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.

TOPICS:

MedNet Solutions Announces the Release of iMedNet EDC

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

MINNETONKA, Minn., March 31, 2011 /- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce that iMedNet™ EDC , the company's innovative, next-generation electronic data capture (EDC) solution,...

TOPICS:

Paul Meade Accepts Invitation to Speak at AACE Annual Meeting

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., March 31, 2011 /- Paul Meade, the president and founder of Thought Leader Select, a Research Triangle, NC company focused on facilitating medical expert collaborations with the biopharmaceutical and other healthcare industries, has accepted an invitation to speak at the...

TOPICS:

Assured Pharmacy Reports Same Store Sales for the Month of January 2011

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

FRISCO, Texas, March 31, 2011 /- Assured Pharmacy (APHY: pinksheets), a leading specialty pharmacy group providing prescription medications to more than 3,000 sufferers of chronic pain, announced that total sales on a same store basis for the month of January  2011 were $1,430,278...

TOPICS:

Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose a generic equivalent of Ferrlecit® Injection by Sanofi Aventis Based on Its...

March 31, 2011 8:37 am | by Bio-Medicine.Org | Comments

EWING, N.J., March 31, 2011 /- Navinta's proprietary complex pharmaceutical ingredient, Sodium Ferric Gluconate as covered under Navinta's US Patent 7,179,939 and US Drug Master File is a key component in the recent approval of GeneraMedix Inc.'s ANDA for Sodium Ferric Gluconate Complex...

TOPICS:

Engineers Without Borders Earns Accolades, Fundraises for Cameroon

March 31, 2011 7:39 am | by Georgia Tech Institute of Technology | Comments

Congratulations go to the Georgia Tech chapter of Engineers Without Borders (EWB-GT), which was honored for its creation of a sustainable solar sanitation system at the National Collegiate Inventors and Innovators Alliance's Open Minds competition last weekend in Washington, D.C. The team...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading